Representation of African-Americans, Hispanics, and whites in National Cancer Institute cancer treatment trials

Journal of the National Cancer Institute

Volumn 88, Issue 12, 1996, Pages 812-816

  Tejeda, Heriberto A ^a,c   Green, Sylvan B ^a   Trimble, Edward L ^a   Ford, Leslie ^a   High, Joseph L ^a   Ungerleider, Richard S ^a   Friedman, Michael A ^b   Brawley, Otis W ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^c SAINT PETER S UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER; CANCER EPIDEMIOLOGY; CANCER PATIENT; CANCER RISK; CAUCASIAN; ETHNIC GROUP; ETHNOLOGY; HUMAN; MAJOR CLINICAL STUDY; NEGRO; RACE;

AFRICAN AMERICANS; CLINICAL TRIALS; EUROPEAN CONTINENTAL ANCESTRY GROUP; HISPANIC AMERICANS; HUMANS; NATIONAL INSTITUTES OF HEALTH (U.S.); NEOPLASMS; UNITED STATES;

EID: 0029950085     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/88.12.812     Document Type: Article

References (18)

1. Report of the Secretary's Task Force on Black and Minority Health. Washington (DC): Department of Health and Human Services, 1985.
2. Department of Health and Human Services, National Institutes of Health. Inclusion of minorities in study populations. NIH Guide 1988;17:2-3.
3. Ungerleider RS, Friedman MA. Sex, trials, and datatapes. J Natl Cancer Inst 1991;83:16-7.
4. Goodwin JS, Hunt WC, Humble CG, Key CR, Samet JM. Cancer treatment protocols. Who gets chosen? Arch Intern Med 1988;148:2258-60.
5. U.S. Department of Commerce. Bureau of the Census. 1990 Census of Population. Data tape STF2C.
6. Gloeckler-Ries LA, Miller BA, Hankey BF, Kosary CL, Harras A, Edwards BK, editors. SEER Program: Surveillance, Epidemiology, and End Results. National Institutes of Health, National Cancer Institute; NIH Publ No. 94-3074, October 1993.
7. Ganz PA. Clinical trials. Concerns of the patient and the public. Cancer 1990;65:2394-9.
8. Taylor KM, Feldstein ML, Skeel RT, Pandya KJ, Ng P, Carbone PP. Fundamental dilemmas of the randomized clinical trial process: results of a survey of the 1,737 Eastern Cooperative Oncology Group investigators [see comment citation in Medline], J Clin Oncol 1994;12: 1796-805.
9. Benson AB 3d, Pregler JP, Bean JA, Rademaker AW, Eshler B, Anderson K. Oncologists' reluctance to accrue patients onto clinical trials: an Illinois Cancer Center study [see comment citations in Medline]. J Clin Oncol 1991;9:2067-75.
10. Hunter CP, Frelick RW, Feldman AR, Bavier AR, Dunlap WH, Ford L, et al. Selection factors in clinical trials: results from the Community Clinical Oncology Program Physician's Patient Log. Cancer Treat Rep 1987; 71:559-65.
11. Frey CM, McMillen MM, Cowan CD, Horm JW, Kessler LG. Representativeness of the Surveillance, Epidemiology, and End Results Program data: recent trends in cancer mortality rates. J Natl Cancer Inst 1992;84:872-7.
12. Thompson IM, Coltman CA, Brawley OW, Ryan A. Chemoprevention of prostate cancer. Semin Ural 1995;13:122-9.
13. Chlebowski RT, Butler J, Nelson A, Lillington L. Breast cancer chemoprevention. Tamoxifen: current issues and future prospective. Cancer 1993;2(3 Suppl):1032-7.
14. Brawley OW, Tejeda H. Minority inclusion in clinical trials: issues and potential strategies. Monogr Natl Cancer Inst 1995;17:55-7.
15. Swanson GM, Ward AJ. Recruiting minorities into clinical trials: toward a participant-friendly system. J Natl Cancer Inst 1995;87:1747-59.
16. NIH Guidelines on the Inclusion of Women and Minorities as Subjects in Clinical Research; Notice. Part VIII, Department of Health and Human Services, National Institutes of Health, Fed Reg March 28, 1994.
17. Freedman LS, Simon R, Foulkes MA, Friedman L, Geller NL, Gordon DJ, et al. Inclusion of women and minorities in clinical trials and the NIH Revitalization Act of 1993 - the perspective of NIH clinical trialists. Control Clin Trials 1995;16:277-85.
18. Williams DR, Lavizzo-Mourey R, Warren RC. The concept of race and health status in America. Public Health Rep 1994;109:26-41.